
According to a survey by the Daily Mail, the "Elfbar 600" product from Elfbar, the largest disposable e-cigarette brand in the UK, has been found to have nicotine levels exceeding the limit by 50%. Current UK regulations state that the nicotine concentration of disposable e-cigarettes must not exceed 2% and the volume must not exceed 2ml.
The Daily Mail has alerted the UK's Medicines and Healthcare products Regulatory Agency (MHRA) to take notice of this matter. Following the release of the investigation results, Elfbar expressed doubt about the investigation process and suggested that the products being investigated might be counterfeit, but a spokesperson for the brand later said, "It has been discovered that some batches of Elfbar 600 products have been overdosed with e-liquid in the UK." On February 5th, Elfbar wrote a letter to the Daily Mail admitting to "unintentionally" breaking the law.
After the investigation results were released, the product was promptly removed from shelves at Tesco supermarkets. Tesco is the UK's largest chain supermarket company, with 2,819 stores in the UK. Additionally, another UK supermarket giant, Morrisons, has also launched an investigation into the product.
It is reported that the Elfbar 600 product sells 2.5 million units per week in the UK, which represents two-thirds of all disposable product sales.
2FIRSTS will continue to follow and report on the latest developments of this event. Stay tuned for updates.
Reference:
The UK's most popular vaping product has been removed from retail shelves due to its nicotine content exceeding the legal limit. The company has acknowledged their error and admitted to unintentionally violating the law.
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.









